These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 36817445)
1. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies. Kapetanakis NI; Busson P Front Immunol; 2023; 14():1145268. PubMed ID: 36817445 [TBL] [Abstract][Full Text] [Related]
2. Roles of Galectin-7 in Cancer. Kaur M; Kaur T; Kamboj SS; Singh J Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627 [TBL] [Abstract][Full Text] [Related]
3. [Galectins in hematological malignancies--role, functions and potential therapeutic targets]. Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306 [TBL] [Abstract][Full Text] [Related]
4. Galectins as regulators of cell survival in the leukemia niche. Ruvolo PP Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264 [TBL] [Abstract][Full Text] [Related]
5. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment. Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445 [TBL] [Abstract][Full Text] [Related]
6. Role of Galectins in Tumors and in Clinical Immunotherapy. Chou FC; Chen HY; Kuo CC; Sytwu HK Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859 [TBL] [Abstract][Full Text] [Related]
7. Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment. Higareda-Almaraz JC; Ruiz-Moreno JS; Klimentova J; Barbieri D; Salvador-Gallego R; Ly R; Valtierra-Gutierrez IA; Dinsart C; Rabinovich GA; Stulik J; Rösl F; Rincon-Orozco B BMC Cancer; 2016 Aug; 16(1):680. PubMed ID: 27558259 [TBL] [Abstract][Full Text] [Related]
8. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139 [TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of Galectins in Cancer : In Vitro and In Vivo Approaches. Martínez-Bosch N; Manero-Rupérez N; Moreno M; Navarro P Methods Mol Biol; 2022; 2442():685-711. PubMed ID: 35320553 [TBL] [Abstract][Full Text] [Related]
11. Galectins in the Tumor Microenvironment: Focus on Galectin-1. Martínez-Bosch N; Navarro P Adv Exp Med Biol; 2020; 1259():17-38. PubMed ID: 32578169 [TBL] [Abstract][Full Text] [Related]
12. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements. Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744 [TBL] [Abstract][Full Text] [Related]
13. Galectin-3: A factotum in carcinogenesis bestowing an archery for prevention. Jeethy Ram T; Lekshmi A; Somanathan T; Sujathan K Tumour Biol; 2021; 43(1):77-96. PubMed ID: 33998569 [TBL] [Abstract][Full Text] [Related]
14. Vascular galectins in tumor angiogenesis and cancer immunity. Thijssen VLJL Semin Immunopathol; 2024 Jul; 46(1-2):3. PubMed ID: 38990363 [TBL] [Abstract][Full Text] [Related]
15. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets. Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916 [TBL] [Abstract][Full Text] [Related]
16. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth. Rivera-Ramos A; Cruz-Hernández L; Talaverón R; Sánchez-Montero MT; García-Revilla J; Mulero-Acevedo M; Deierborg T; Venero JL; Sarmiento Soto M Cancer Lett; 2024 Jun; 591():216879. PubMed ID: 38636895 [TBL] [Abstract][Full Text] [Related]
17. Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy. Lau LS; Mohammed NBB; Dimitroff CJ Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555198 [TBL] [Abstract][Full Text] [Related]
18. Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer. Gentilini LD; Jaworski FM; Tiraboschi C; Pérez IG; Kotler ML; Chauchereau A; Laderach DJ; Compagno D Oncotarget; 2017 Jul; 8(27):44654-44668. PubMed ID: 28591719 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Galectin-Binding Receptors on B Cells. Chakraborty A; Mohammed NBB; Bernasconi AE; Dimitroff CJ Methods Mol Biol; 2022; 2442():565-580. PubMed ID: 35320546 [TBL] [Abstract][Full Text] [Related]
20. Role of Galectins in Multiple Myeloma. Storti P; Marchica V; Giuliani N Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]